Skip to content
value.today

Tiger Biotherapeutics Inc.

Total raised
$20 M
1 round on record
Latest round
$20 M
Mar 2023
First round on record
Mar 2023
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Tiger Biotherapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2023$20 MNo. 1$10 to $50 million

Tiger Biotherapeutics Inc.: Raise no. 1, Mar 2023

Investors in this round

4 investors had bought by the notice of Apr 5, 2023: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $22 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jie FAN · Executive Officer, Director
  • Bihua Chen · Director
  • Quan ZHOU · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jie FAN, Ceo. Newest notice filed Apr 5, 2023. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tiger Biotherapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2023).

    SEC Form D · Apr 2023

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Apr 2023

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tiger Biotherapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tiger Biotherapeutics Inc.
NameRoleNamed in
Jie FANExecutive officerApr 2023
Bihua ChenDirectorApr 2023
Jie FANDirectorApr 2023
Quan ZHOUDirectorApr 2023